Director, Global Value & Access Strategy, povetacicept

Vertex Pharmaceuticals • Boston, MA

14d • Hybrid

About The Position

Vertex operates at the forefront of scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF) as well as Casgevy, a gene therapy for sickle cell disease and beta-thalassemia. Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in Pain, APOL-1 mediated kidney disease (AMKD), and cell therapies for Type 1 diabetes, among others. Povetacicept is a highly potent and effective dual antagonist of BAFF and APRIL pathways with potential best-in-class efficacy in patients with IgA nephropathy (IgAN) and primary membranous nephropathy (pMN). IgAN is a serious, progressive, autoimmune disease of the kidney that can lead to end-stage-renal disease. There are no approved therapies that target the underlying cause of IgAN. IgAN is the most common cause of primary (idiopathic) glomerulonephritis worldwide. Due to its mechanism of action as a dual BAFF/APRIL antagonist, povetacicept holds the potential to benefit patients for multiple serious diseases including other autoimmune kidney diseases and autoimmune cytopenias. Vertex is expanding its Global Value and Access Strategy (GVAS) team to support the launch of this exciting product. Market Access is a key commercial function that ensures transformative Vertex therapies are appropriately funded and ultimately make it into the hands of the patients around the world. GVAS works cross-functionally and across regions to ensure the payer view is represented in commercial and development plans across the lifecycle. We are driven by a desire to deliver groundbreaking pricing & reimbursement solutions to allow our medicines to reach patients faster than ever before. The Director, Global Value & Access Strategy, povetacicept role will support the asset with a primary focus on launch readiness for new indications and LCM . In this capacity, the individual will be responsible for the global price & access strategy and value communications. This individual will also directly contribute to the life-cycle strategy for the asset, ensuring price and access success. This role will also be accountable for leadership of cross-portfolio capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving Global payer environment. The role reports to Global Value & Access Strategy Lead, povetacicept.

Requirements

• 8+ years of direct biotechnology / pharmaceutical industry experience and/or payer experience
• Deep working knowledge of both US and ex-US healthcare systems required, experience in comparable global and/or specialty disease area role considered a plus
• Demonstrated ability to think strategically and make sound pricing and market access recommendations
• Entrepreneurial, energetic, dynamic, enthusiastic, decisive, and self-motivated; possesses a sense of urgency with the ability and strong desire to "make things happen"
• Strong practical, quantitative and analytical skills combined with a sound understanding of how to successfully apply pricing & reimbursement / HEOR principles
• General experience in commercialization and drug development
• Demonstrated ability to effectively operate within highly cross-functional teams within a matrix environment
• Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Vertex
• Demonstrated relationship building at all levels of the organization and across geographies
• Recognized as a team player with excellent interpersonal skills who is flexible and reliable
• Displays sound ethics and a fit for Vertex’s core values
• BA/BS in field of study requiring quantitative analysis; advanced degree preferred

Responsibilities

• Ensure launch readiness for new indication(s): Partner cross-functionally and cross-Regionally to ensure robust, differentiated value proposition and integrated evidence plans to support global market access and value
• Develop of the global pricing and market access strategy, payment models and negotiation approach
• Lead development of global strategic payer plan and evidence prioritization in the evidence generation plan
• Drive delivery of unbranded, branded payer value communications and supportive training
• Life-cycle management: Partner cross functionally to shape LCM strategy, including indication sequencing
• Identify, prioritize and champion evidence required for access enabling trials and value optimization; determine minimum reimbursable profiles
• Accountable for ensuring the market access and payer perspective is reflected in cross-functional strategies (e.g. commercial, product development, regulatory affairs)
• Collaborate closely with HEOR, regional market access, global commercial strategy, clinical development, medical affairs and corporate affairs counterparts to ensure value & access optimization
• Maintain industry awareness and proactively address changes in market trends, competition, product acceptance and new product releases and adjust market access plans accordingly

Benefits

• annual bonus
• annual equity awards
• medical, dental and vision benefits
• generous paid time off (including a week-long company shutdown in the Summer and the Winter)
• educational assistance programs including student loan repayment
• a generous commuting subsidy
• matching charitable donations
• 401(k)

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Number of Employees: 5,001-10,000 employees